Contact
Please use this form to send email to PR contact of this press release:
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A
TO:
Please use this form to send email to PR contact of this press release:
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A
TO: